Daniel Roessler

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report.

Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report.

Journal: Oncology research and treatment

Published: January 26, 2025

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis.

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis.

Journal: Journal of hepatocellular carcinoma

Published: December 31, 2024

Cross-Professional Evaluation of 3D Visualization of Liver Malignancies in the Decade of AI and Automatic Segmentation: A Benefit for Multidisciplinary Teams and Tumor Board Decisions?

Cross-Professional Evaluation of 3D Visualization of Liver Malignancies in the Decade of AI and Automatic Segmentation: A Benefit for Multidisciplinary Teams and Tumor Board Decisions?

Journal: Cureus

Published: October 24, 2024

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma.

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma.

Journal: Alimentary pharmacology & therapeutics

Published: March 16, 2024

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Journal: Hepatology communications

Published: February 05, 2024

Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.

Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.

Journal: Digestive diseases (Basel, Switzerland)

Published: January 16, 2024

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 10, 2023

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

Journal: Targeted oncology

Published: July 13, 2023

Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy.

Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy.

Journal: JCO precision oncology

Published: June 26, 2023

Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis.

Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis.

Journal: Oncology research and treatment

Published: May 12, 2023

Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study.

Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 14, 2023

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.

Journal: Radiation oncology (London, England)

Published: February 18, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026